Suraj Kalia
Stock Analyst at Oppenheimer
(3.87)
# 709
Out of 5,044 analysts
84
Total ratings
46.48%
Success rate
12.42%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Downgrades: Perform | n/a | $82.19 | - | 6 | Oct 8, 2025 | |
| PRCT PROCEPT BioRobotics | Upgrades: Outperform | $60 | $36.95 | +62.38% | 2 | Sep 2, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $17.35 | +26.80% | 1 | Jul 7, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $129.71 | +15.64% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $36.45 | +23.46% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $12.48 | +84.29% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $182.67 | -34.31% | 6 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $45.26 | -29.30% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $89.63 | +3.76% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $126.61 | +2.68% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $10 | $4.92 | +103.46% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $5.01 | +159.48% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $68.00 | +98.53% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $256.57 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $15.35 | +95.44% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $2.10 | +9,423.81% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $79.40 | +22.17% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $28.01 | -0.04% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $2.21 | +103.62% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.70 | +841.18% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $545.39 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $2.14 | +30,741.12% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $77.17 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $3.89 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $22.86 | +337.45% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $69.23 | - | 5 | Sep 12, 2018 |
Edwards Lifesciences
Oct 8, 2025
Downgrades: Perform
Price Target: n/a
Current: $82.19
Upside: -
PROCEPT BioRobotics
Sep 2, 2025
Upgrades: Outperform
Price Target: $60
Current: $36.95
Upside: +62.38%
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $17.35
Upside: +26.80%
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $129.71
Upside: +15.64%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $36.45
Upside: +23.46%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $12.48
Upside: +84.29%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $182.67
Upside: -34.31%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $45.26
Upside: -29.30%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $89.63
Upside: +3.76%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $126.61
Upside: +2.68%
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $4.92
Upside: +103.46%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $5.01
Upside: +159.48%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $68.00
Upside: +98.53%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $256.57
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $15.35
Upside: +95.44%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $2.10
Upside: +9,423.81%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $79.40
Upside: +22.17%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $28.01
Upside: -0.04%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $2.21
Upside: +103.62%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $1.70
Upside: +841.18%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $545.39
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $2.14
Upside: +30,741.12%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $77.17
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $3.89
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $22.86
Upside: +337.45%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $69.23
Upside: -